By Bryan Koenig
Law360 (December 20, 2018, 8:19 PM EST) -- Patent infringement lawsuits challenging generic drug applications aren’t automatically immune from antitrust claims, a New Jersey federal judge ruled Wednesday, refusing to toss counterclaims accusing Takeda Pharmaceutical Co. Ltd. of trying...Takeda’s Patent Infringement Suit Not Antitrust-Proof
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login